Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of S-1 Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer in Taiwan

NCT04070313 is registered in ClinicalTrials.gov with TTY Biopharm as lead sponsor.

NCT NCT04070313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04070313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of S-1 Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer in Taiwan
Lead sponsor
TTY Biopharm
Phase
Phase 2
Overall status
Terminated
Start date
July 11, 2019
Completion date
October 31, 2021
Enrollment
36 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

adjuvant chemotherapy, pancreatic cancer, resected pancreatic cancer